Cytokines and ovarian cancer

  • M. S. Naylor
  • F. Burke
  • F. R. Balkwill


Cytokines can influence the growth and spread of a tumour in both positive and negative ways. Endogenous cytokines or those used as therapy may act as direct cytostatic agents preventing cell proliferation and encouraging differentiation. In some microenvironments, particularly when nutritional conditions are suboptimal, cytokines may also be cytotoxic, initiating apoptosis of the tumour cells. Therapeutic administration, local endogenous cytokines or genetically engineered local cytokine production may stimulate host immune responses to the tumour leading to cell and cytokine mediated destruction of the malignant cells. Under certain circumstances cytokines can also mediate destruction of the tumour neovasculature or deplete the tumour environment of essential nutrients.


Ovarian Cancer Idiopathic Pulmonary Fibrosis Tumour Necrosis Factor Receptor Human Ovarian Cancer Tumour Necrosis Factor Antagonist 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Old, L.J. (1985) Tumour necrosis factor (TNF). Science, 230, 630.PubMedCrossRefGoogle Scholar
  2. 2.
    Palladino, M.A., Refaat Shalaby, M., Dramer, S.M. et al, (1987) Characterization of the antitumour activities of human tumor necrosis factor alpha and the comparison with other cytokines: induction of tumor-specific immunity. J. Immunol., 138,4023.PubMedGoogle Scholar
  3. 3.
    Creasey, A.A., Reynolds, M.T. and Laird, W. (1986) Cures and partial regression of murine and human tumors by recombinant human tumor necrosis factor. Cancer Res., 46,5687–90.PubMedGoogle Scholar
  4. 4.
    Piers, W. (1991) Tumor necrosis factor: characterisation at the molecular, cellular and in vivo, level. FEBS, 285,199–212.CrossRefGoogle Scholar
  5. 5.
    Sugarman, B.J., Aggarwal, B.B., Hass, P.E. et al, (1985) Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. Science, 230, 943.Google Scholar
  6. 6.
    Dvorak, H.F. (1986) Tumours: wounds that do not heal. N. Engl J. Med., 315,1650–9.PubMedCrossRefGoogle Scholar
  7. 7.
    Gerlach, H., Liebermann, H., Brett, J. et al., (1989) Growing/motile endothelium shows enhanced responsiveness to tumor necrosis factor/cachectin. J. Exp. Med., 170, 913–31.PubMedCrossRefGoogle Scholar
  8. 8.
    Frater-Schroder, M., Risau, W. Hallaman, R. et al., (1987) Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc. Natl. Acad. Sci. USA, 84, 5277–87.CrossRefGoogle Scholar
  9. 9.
    Ito, A., Sato, T., Iga, T. and Mori, Y. (1990) Tumor necrosis factor bifunctionally regulates matrix metalloproteinases and tissue inhibitor of metalloproteinases (TIMP) production by human fibroblasts. FEBS, 269, 93–5Google Scholar
  10. 10.
    Brenner, D.A., O’Hara, M., Angel, P. et al., (1989) Prolonged activation of jun and collagenase genes by tumor necrosis factor-alpha. Nature, 337, 661.PubMedCrossRefGoogle Scholar
  11. 11.
    Liotta, L.A. and Stetler Stevenson, W.G. (1991) Tumor invasion and metastasis: an imbalance of positive and negative regulation.Cancer Res., 51, 5054s-9s.PubMedGoogle Scholar
  12. 12.
    Malik, S.T.A., Griffin, D.B., Fiers, W. and Balkwill, F.R. (1989) Paradoxical effects of tumor necrosis factor in experimental ovarian cancer.Int. J. Cancer, 44, 918–25.PubMedCrossRefGoogle Scholar
  13. 13.
    Spriggs, D., Imamura, K., Rodriguez, C. et al., (1987) Induction of tumor necrosis factor expression and resistance in a human breast tumor cell line. Proc. Natl Acad. Sci. USA, 84, 6563–6.PubMedCrossRefGoogle Scholar
  14. 14.
    Piguet, P.F., Ribaux, C. Karpuz, al, (1992) Cellular origin of pulmonary tumor necrosis factor (TNF) during idiopathic pulmonary fibrosis. Eur. Cytokine Netw, 3, 255 (abs).Google Scholar
  15. 15.
    Niitsu, Y., Watanabe, N., Neda, H. et al, (1988) Induction of synthesis of tumor necrosis factor in human and marine cells by exogenous recombinant human tumor necrosis factor. Cancer Res., 48, 5407–10.PubMedGoogle Scholar
  16. 16.
    Baiocchi, G., Kavanagh, J.J., Talpaz, M. et al, (1991) Expression of the macrophage colony stimulating factor and its receptor in gynecologic malignancies. Cancer, 67, 990–6.PubMedCrossRefGoogle Scholar
  17. 17.
    Abruzzo, L.V., Thornton, A.J., Liebert, M. et al, (1992) Cytokine-induced gene expression of interleukin 8 in human transitional cell carcinomas and renal cell carcinomas. Am. J. Pathol., 140, 365–73.PubMedGoogle Scholar
  18. 18.
    Aderka, D., Engelmann, H., Hirnik, V. et al, (1991) Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients. Cancer Res., 51, 5602–7.PubMedGoogle Scholar
  19. 19.
    Allavena, P., Peccatori, F., Maggioni, D. et al, (1990) Intraperitoneal recombinant g-interferon in patients with recurrent ascitic ovarian carcinoma: modulation of cytotoxicity and cytokine production in tumor associated effectors and of major histocompatibility antigen expression on tumor cells. Cancer Res., 50, 7318–23.PubMedGoogle Scholar
  20. 20.
    D’Acquisto, R., Markman, M., Hakes, T. et al, (1988) A phase I trial of intraperitoneal recombinant g-interferon in advanced ovarian carcinoma. J. Clin. Oncol., 6, 689–95.PubMedGoogle Scholar
  21. 21.
    Pujade-Lauraine, E., Guastella, J.P., Colombo, N. et al, (1991) Intraperitoneal human r-IFN-gamma as treatment of residual carcinoma (OC) and laparotomy (SLL). Proc. ASCO, 10,195.Google Scholar
  22. 22.
    Ward, B.G, Wallace, K., Shepherd, J.H. and Balkwill, F.R. (1987) Intraperitoneal xenografts of human epithelial cancer in nude mice. Cancer Res., 47, 2662–7.PubMedGoogle Scholar
  23. 23.
    Malik, S.T.A., Knowles, R.G., East N. et al, (1991) Antitumor activity of γ -interferon in ascitic and solid tumor models of human ovarian cancer. Cancer Res., 51, 6643–9.PubMedGoogle Scholar
  24. 24.
    Ozaki, Y., Edelstein, M. and Duch, D. (1988) Induction of indoleamine 2,3 dioxygenase: a mechanism of the antitumour activity of interferon-γ. Proc. Natl Acad. Sci. USA, 85,1242–6.PubMedCrossRefGoogle Scholar
  25. 25.
    Takikawa, O., Kuroiwa, T., Yamazaki, F. and Kido, R. (1988) Mechanism of interferon- γ action. J. Biol Chem., 263, 2041–8.PubMedGoogle Scholar
  26. 26.
    Evan, G.I. and Littlewood, T.D. (1993) The role of c-myc, in cell growth. Curr. Opin. Genet. Develop., 3,44–9.CrossRefGoogle Scholar

Copyright information

© Chapman & Hall 1995

Authors and Affiliations

  • M. S. Naylor
  • F. Burke
  • F. R. Balkwill

There are no affiliations available

Personalised recommendations